Key Highlights
- DarioHealth’s acquisition of Twill marks a significant expansion in digital health, targeting a broad range of chronic conditions.
- Expected to nearly double pro forma 2023 revenue and reach gross margins of 80-85% by 2025.
- The acquisition enables immediate scale and cost synergies, accelerating the path to profitability within two years.
Source: PR Newswire
Notable Quotes
- “The Twill acquisition is an incredible opportunity to bring together our complementary solutions and create an unrivaled platform for the next generation of consumer-centric digital health. It’s rare to find not just alignment, but shared passion igniting a collaboration. That’s exactly what we’ve discovered in Twill,” – Erez Raphael, CEO at Dario
- “This shared vision fuels our powerful union, transforming data into a vibrant tapestry of individual health stories,” – Tomer Ben-Kiki, Co-Founder and CEO at Twill
SoHC's Take
The merger between DarioHealth and Twill represents a groundbreaking move in the digital health industry, combining Dario’s comprehensive digital therapeutics platform with Twill’s innovative digital-led care solutions. This strategic acquisition is poised to reshape the landscape of chronic condition management by leveraging technology to empower consumers, enhance engagement, and streamline care delivery. With a focus on expanding its digital health solutions, DarioHealth is set to achieve unprecedented scale, enhancing its market position and accelerating its journey towards profitability. The acquisition not only signifies a leap forward in offering a unified solution for managing a wide range of chronic conditions but also underscores the importance of technology in revolutionizing healthcare delivery and improving patient outcomes.
